Last reviewed · How we verify
NCT06171841
Effects of Low-Intensity Blood Flow Restriction Training in Normoxia and Hypoxia Conditions
NA trial testing low-intensity resistance training in Hypoxia, Altitude in 60 participants. Participants enrolled and being followed up; not accepting new ones.
20 June 2024
Quick facts
| Lead sponsor | The Jerzy Kukuczka Academy of Physical Education in Katowice |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 20 November 2023 |
| Primary completion | 20 June 2024 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- low-intensity resistance training
- high-intensity resistance training
- low-intensity resistance training combined with blood flow restriction
- low-intensity resistance training in hypoxia condition
- low-intensity resistance training combined with blood flow restriction in hypoxia condition
Conditions studied
- Hypoxia, Altitude — all drugs for Hypoxia, Altitude →
- Blood Flow Restriction — all drugs for Blood Flow Restriction →
- Resistance Training — all drugs for Resistance Training →
Sponsor
The Jerzy Kukuczka Academy of Physical Education in Katowice
Who can join
Adults 18 to 30, any sex, with Hypoxia, Altitude or Blood Flow Restriction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
One approach to significantly reducing resistance training intensity while maintaining effectiveness in muscle mass and strength development involves conducting training sessions under hypoxic conditions. This is likely due to heightened physiological responses. While sports science research indicates a substantial impact of hypoxic conditions on immediate increases in metabolic stress and augmented hormonal responses, recent findings suggest that the role of their influence on skeletal muscle adaptations post-resistance training under hypoxic conditions remains unknown. Additionally, there is a lack of reports on whether the type of hypoxia applied via blood flow restriction or chamber differentiates the increase in secretion of these catecholamines in both immediate and long-term aspects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06171841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Jerzy Kukuczka Academy of Physical Education in Katowice trials
Trials by the same sponsor.
- NCT07482254 — Acute Effects of Isometric Conditioning on Sprint, Jump and Change of Direction Performance in Youth Soccer Players · NA · enrolling by invitation
- NCT07297251 — Temporomandibular Joints Mobility and Head Posture: Influence of Manual Therapy and Exercises in Dental Patients. · NA · not yet recruiting
- NCT07483931 — Priming Magnitude and Retention in Highly Trained Male Volleyball Players · NA · completed
- NCT06959329 — Influence of Sensory Stimulation on Sensory Parameters and Motor Function in Children With Developmental Coordination Di · NA · not yet recruiting
- NCT06982937 — Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Rando · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06171841 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Jerzy Kukuczka Academy of Physical Education in Katowice
- Last refreshed: 11 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing